(S)-4-Isopropyl-5,5-diphenyloxazolidin-2-one, 95.0%, 250mg

(butylsulfanyl)methanimidamide hydrobromide, 95.0%, 5g

3-[6-Methyl-4-(trifluoromethyl)pyridin-2-yl]benzoic acid, 95.0%, 500mg

5-azetidin-3-yl-3-(2-thienylmethyl)-1,2,4-oxadiazole hydrochloride, 95.0%, 250mg

Tungstophosphoric acid hydrate, pa, cryst., 50 g, glass packaging

2,5-Dioxopyrrolidin-1-yl 2-(4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)acetate, 98%, 250mg

(5,6-Dimethyl-9-oxo-xanthen)-4-acetic acid, 95.0%, 25mg

Ethyl 6-bromo-3-chloro-5-methylpyrazine-2-carboxylate, 95%, 1g

3-(PYRIDIN-4-YLOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 5g

2,3,4,4'-Tetrahydroxybenzophenone>98.0%(T)25g

tert-Butyl (6-fluoropyridin-2-yl)carbamate, 98%, 2g

2-Ethylisonicotinonitrile, 97.0%, 1g

3,6-DICHLORO-1,2,4-TRIAZINE, 95%, 5g